Scientists have identified alterations in the mpox virus genome that potentially correlate with changes in viral transmissibility observed in the 2022 outbreak (Nat Commun 2024;15[1]. doi:10.1038/s41467-024-46949-7).
Mount Sinai scientists with researchers from the Carlos III Health Institute in Madrid, Spain, analyzed samples from 46 patients infected with mpox whose diagnosis and sequencing were carried out at the institute early in the 2022 mpox outbreak. The team